These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 19120514)

  • 1. Three-dimensional 26-core biopsy-based patient selection criteria for nerve-sparing radical prostatectomy.
    Numao N; Kawakami S; Yonese J; Koga F; Saito K; Fujii Y; Ishikawa Y; Fukui I; Kihara K
    Int J Urol; 2008 Dec; 15(12):1061-6. PubMed ID: 19120514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved accuracy in predicting the presence of Gleason pattern 4/5 prostate cancer by three-dimensional 26-core systematic biopsy.
    Numao N; Kawakami S; Yokoyama M; Yonese J; Arisawa C; Ishikawa Y; Ando M; Fukui I; Kihara K
    Eur Urol; 2007 Dec; 52(6):1663-8. PubMed ID: 17240041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor length and location of cancer on biopsy predict for side specific extraprostatic cancer extension.
    Naya Y; Slaton JW; Troncoso P; Okihara K; Babaian RJ
    J Urol; 2004 Mar; 171(3):1093-7. PubMed ID: 14767278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of extraprostatic extension in the neurovascular bundle based on prostate needle biopsy pathology, serum prostate specific antigen and digital rectal examination.
    Tsuzuki T; Hernandez DJ; Aydin H; Trock B; Walsh PC; Epstein JI
    J Urol; 2005 Feb; 173(2):450-3. PubMed ID: 15643200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sextant prostate biopsies predict side and sextant site of extracapsular extension of prostate cancer.
    Elliott SP; Shinohara K; Logan SL; Carroll PR
    J Urol; 2002 Jul; 168(1):105-9. PubMed ID: 12050501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of extraprostatic extension in men with biopsy Gleason score of 8 or greater.
    Nakanishi H; Troncoso P; Babaian RJ
    J Urol; 2008 Dec; 180(6):2441-5; discussion 2445-6. PubMed ID: 18930495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved accuracy for predicting the Gleason score of prostate cancer by increasing the number of transrectal biopsy cores.
    Miyake H; Kurahashi T; Takenaka A; Hara I; Fujisawa M
    Urol Int; 2007; 79(4):302-6. PubMed ID: 18025846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship between tumor volume and the number of positive cores in men undergoing multisite extended biopsy: implication for expectant management.
    Ochiai A; Troncoso P; Chen ME; Lloreta J; Babaian RJ
    J Urol; 2005 Dec; 174(6):2164-8, discussion 2168. PubMed ID: 16280756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of extracapsular extension of prostate cancer based on systematic core biopsies.
    Tarján M; Tot T
    Scand J Urol Nephrol; 2006; 40(6):459-64. PubMed ID: 17130097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can prostate biopsies predict suitability for nerve-sparing radical prostatectomy?
    Connolly SS; O'Malley KJ; O'Brien A; Kelly DG; Mulvin DW; Quinlan DM
    Scand J Urol Nephrol; 2004; 38(3):216-20. PubMed ID: 15204374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Location of a positive biopsy as a predictor of surgical margin status and extraprostatic disease in radical prostatectomy.
    Touma NJ; Chin JL; Bella T; Sener A; Izawa JI
    BJU Int; 2006 Feb; 97(2):259-62. PubMed ID: 16430624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Six additional systematic lateral cores enhance sextant biopsy prediction of pathological features at radical prostatectomy.
    Singh H; Canto EI; Shariat SF; Kadmon D; Miles BJ; Wheeler TM; Slawin KM
    J Urol; 2004 Jan; 171(1):204-9. PubMed ID: 14665877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate biopsy clinical and pathological variables that predict significant grading changes in patients with intermediate and high grade prostate cancer.
    Moussa AS; Li J; Soriano M; Klein EA; Dong F; Jones JS
    BJU Int; 2009 Jan; 103(1):43-8. PubMed ID: 18782303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Side-specific factors associated with extracapsular extension and seminal vesicular invasion in men undergoing open radical retropubic prostatectomy.
    Sankin A; Tareen B; Lepor H
    Prostate Cancer Prostatic Dis; 2009; 12(2):204-8. PubMed ID: 19238170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Development of a preoperative criterion to select candidates for nerve-sparing radical prostatectomy at Kyoto University Hospital].
    Mizuno K; Inoue T; Miyazaki Y; Makino Y; Terada N; Kobayashi T; Yamasaki T; Matsui Y; Kamba T; Yoshimura K; Mikami Y; Ogawa O
    Hinyokika Kiyo; 2014 Nov; 60(11):543-7. PubMed ID: 25511940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radical prostatectomy for high-risk prostate cancer: biochemical outcome.
    Kawamorita N; Saito S; Ishidoya S; Ito A; Saito H; Kato M; Arai Y
    Int J Urol; 2009 Sep; 16(9):733-8. PubMed ID: 19674167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of pathological stages before prostatectomy in prostate cancer patients: analysis of 12 systematic prostate needle biopsy specimens.
    Park EA; Lee HJ; Kim KG; Kim SH; Lee SE; Choe GY
    Int J Urol; 2007 Aug; 14(8):704-8. PubMed ID: 17681059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increasing the number of biopsy cores improves the concordance of biopsy Gleason score to prostatectomy Gleason score.
    Coogan CL; Latchamsetty KC; Greenfield J; Corman JM; Lynch B; Porter CR
    BJU Int; 2005 Aug; 96(3):324-7. PubMed ID: 16042723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of radial distance of extraprostatic extension from pretherapy factors.
    Schwartz DJ; Sengupta S; Hillman DW; Sargent DJ; Cheville JC; Wilson TM; Mynderse LA; Choo R; Davis BJ
    Int J Radiat Oncol Biol Phys; 2007 Oct; 69(2):411-8. PubMed ID: 17869661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of criteria used to predict extraprostatic cancer extension: a tool for use in selecting patients for nerve sparing radical prostatectomy.
    Kamat AM; Jacobsohn KM; Troncoso P; Shen Y; Wen S; Babaian RJ
    J Urol; 2005 Oct; 174(4 Pt 1):1262-5. PubMed ID: 16145389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.